1. Home
  2. ZCMD vs BMRA Comparison

ZCMD vs BMRA Comparison

Compare ZCMD & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zhongchao Inc.

ZCMD

Zhongchao Inc.

HOLD

Current Price

$1.55

Market Cap

7.9M

Sector

Real Estate

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$2.24

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZCMD
BMRA
Founded
2012
1971
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9M
6.8M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
ZCMD
BMRA
Price
$1.55
$2.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.5K
13.2K
Earning Date
04-28-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$1.87
52 Week High
$2.29
$4.60

Technical Indicators

Market Signals
Indicator
ZCMD
BMRA
Relative Strength Index (RSI) 30.84 58.23
Support Level $1.44 $2.11
Resistance Level $1.94 $2.40
Average True Range (ATR) 0.19 0.05
MACD -0.08 0.00
Stochastic Oscillator 3.25 100.00

Price Performance

Historical Comparison
ZCMD
BMRA

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provides healthcare information, education, and training services to healthcare professionals under its MDMOOC brand. It also provides focused patient management services through the Zhongxun IT system and WeChat mini program, and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: